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A B S T R A C T 
Acute ischaemic stroke due to large vessel occlusion 
leads to grave neurological morbidity and mortality. 
Conventional intravenous thrombolysis is ineffective 
in achieving timely reperfusion in this group of 
patients. The publication of five positive randomised 
controlled trials of emergency thrombectomy for 
acute ischaemic stroke in 2015 provided strong 
evidence to support endovascular reperfusion 
therapy and represented a paradigm shift in acute 
stroke management. In this article, we review the 
current evidence and international guidelines, 
and report on the findings of a survey study of the 
clinical practice and opinions of local neurologists, 
neurosurgeons, and interventional radiologists in 
emergency thrombectomy. We also discuss the 
controversies around thrombectomy treatment, 
local experience, and suggestions to incorporate 
Emergency thrombectomy for acute ischaemic 
stroke: current evidence, international guidelines, 
and local clinical practice
Introduction
Before 2015, the standard of care for emergency 
ischaemic stroke treatment was intravenous 
thrombolysis with tissue plasminogen activator (IV-
tPA). This stemmed from the National Institute of 
Neurological Disorders and Stroke trial in 1995, 
which showed that compared with placebo, patients 
who were given IV-tPA within 3 hours from symptom 
onset were 30% more likely to have minimal or no 
disability at 3 months.1 The therapeutic window 
was further extended to 4.5 hours from symptom 
onset by the European Cooperative Acute Stroke 
Study III, which demonstrated similar benefits when 
IV-tPA was administered between 3 and 4.5 hours to 
selected patients.2
 Nonetheless, in patients with ischaemia due 
to occlusion of a major cerebral artery, such as the 
intracranial internal carotid artery or the first and 
second segment of middle cerebral artery (M1, M2), 
the efficacy of intravenous thrombolysis was limited, 
with a recanalisation rate of only 4% to 30%.3 This 
group of patients frequently had a grave neurological 
prognosis and high mortality owing to the large 
infarct territory, and could develop malignant cerebral 
oedema that required decompressive craniectomy.4
 To improve the recanalisation rate, 
endovascular mechanical thrombectomy to remove 
the occluding clot was proposed. Early studies of 
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this technique showed conflicting results and were 
attributed to poor patient selection and suboptimal 
endovascular devices that resulted in a low 
recanalisation rate, thus failing to show the expected 
benefits of endovascular thrombectomy.5-7
 With modern improved thrombectomy 
devices, the publication of five positive randomised 
trials of acute mechanical thrombectomy for 
ischaemic stroke resulting from anterior circulation 
large-vessel occlusion in the New England Journal of 
Medicine in 2015 marked a paradigm shift in stroke 
treatment.8-12 Since then, emergency endovascular 
thrombectomy has been internationally regarded 
as the new standard of care for acute ischaemic 
stroke caused by major vessel occlusion, and is 
recommended by all major stroke guidelines.
Summary of current evidence
The five independent randomised controlled 
trials that provided strong evidence to support 
endovascular thrombectomy were MR CLEAN,8 
REVASCAT,9 ESCAPE,10 EXTEND-IA,11 and SWIFT 
PRIME,12 conducted in the US, Europe, and Australia 
from 2010 to 2015. Although there were differences 
in terms of inclusion and exclusion criteria, all five 
studies recruited only acute stroke patients with 
angiogram-proven major vessel occlusion in the 
anterior circulation, and used newer-generation 
Medical PracticeCME
thrombectomy in acute stroke treatment.
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血栓移除術治療急性缺血性中風：當前證據， 
國際指引和本地臨床實踐
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因大血管閉塞引起的急性缺血性中風，會導致嚴重神經性殘障和死
亡。傳統的靜脈溶栓對於打通大血管閉塞的療效有限。2015年發表的
五項有關急性血栓塞的隨機對照研究，證實經動脈血管的血栓移除術
可應用於急性缺血性中風治療，同時亦代表了急性腦中風治理的新標
準。本文回顧當前的證據和國際指引，並報告一個以本地神經內科醫
生、神經外科醫生和介入放射科醫生為對象的問卷調查，探討他們對
於急性血栓移除術的臨床實踐和意見。本文續討論關於血栓移除治療
的爭議和本地的經驗，以及在香港急性腦中風治療中普及應用血栓移
除術的建議。
thrombectomy devices (mostly stent retrievers) that 
achieved higher recanalisation rates than earlier 
devices used in previous trials.
 All patients in the five trials were given IV-tPA 
as standard treatment when eligible, and were then 
randomised to receive endovascular thrombectomy 
or standard care alone. All these trials unanimously 
showed significant benefit in the thrombectomy 
group in terms of improved functional outcome at 
3 months, as measured by the modified Rankin scale 
(mRS) [Table 18-13].
Functional outcome benefit
A meta-analysis of the above five trials with a total 
of 1287 eligible patients showed that 46% of patients 
treated by endovascular thrombectomy achieved 
functional independence (mRS score, 0-2) at 90 
days, compared with 26.5% of patients in the control 
group13 (Table 1). The number needed-to-treat was 
2.6 for one patient to improve functionally by at 
least 1 point on mRS. In terms of safety, there was 
no significant difference between the intervention 
group and the control group in symptomatic 
intracranial haemorrhage (4.4% vs 4.3%; P=0.81) or 
mortality rate at 90 days (15.3% vs 18.9%; P=0.15).13
 Moreover, the clinical benefit was maintained 
whether the patient was eligible to receive IV-tPA in 
the first place, and across all age-groups including 
the patients older than 80 years. Patients improved 
after thrombectomy regardless of the initial severity 
of stroke, as documented by the National Institutes 
of Health Stroke Scale (NIHSS) and the initial 
Alberta Stroke Program Early CT Score.
Therapeutic time frame
Regarding the treatment time frame, thrombectomy 
within 6 hours from symptom onset was consistently 
beneficial across all five thrombectomy trials. In 
the REVASCAT trial that included patients within 
8 hours of symptom onset, the median onset-to-
reperfusion time was still within 6 hours in the 
thrombectomy group, although no separate data 
were provided for those who presented between 6 
and 8 hours.9 Similarly, in the ESCAPE trial, which 
included patients up to 12 hours from stroke onset, 
the median time to reperfusion was 4 hours from 
symptom onset and very few patients beyond 6 
hours were recruited.10 At present, two clinical 
trials are underway to investigate the benefits of 
endovascular thrombectomy for anterior circulation 
stroke beyond 6 hours, and both require computed 
tomography (CT) perfusion or magnetic resonance 
imaging (MRI) to assess infarct core and perfusion 
mismatch to determine eligibility (NCT02586415, 
NCT02142283). Therefore, the efficacy and risk of 
anterior circulation thrombectomy beyond 6 hours 
without advanced imaging selection criteria are 
uncertain, and should be performed with discretion 
or in a clinical research setting.
Posterior circulation and the paediatric 
population
At present, there is no evidence from randomised 
Abbreviations: CI = confidence interval; mRS = modified Rankin scale
* P<0.05
TABLE 1.  Summary of functional outcome and mortality at 90 days of five thrombectomy for ischaemic stroke trials8-13
No. of patients mRS score 0-2 at 90 days Odds ratio 
(95% CI)
Mortality at 90 days
Thrombectomy 
group (%)
Control group 
(%)
Thrombectomy 
group (%)
Control group 
(%)
MR CLEAN8 500 32.6 19.1* 2.05 (1.36-3.09) 13.0 22.1
ESCAPE10 316 53.0 29.3* 2.73 (1.71-4.37) 10.3 19.0*
SWIFT PRIME12 196 51.0 35.5* 2.75 (1.53-4.94) 9.2 15.5
REVASCAT9 205 43.7 28.2* 1.98 (1.11-3.53) 18.4 15.5
EXTEND-IA11 70 82.6 40.0* 3.75 (1.38-10.17) 8.6 20.0
HERMES meta-analysis13 1287 46.0 26.5* - 15.3 18.9
#  Emergency thrombectomy for acute ischaemic stroke  # 
75Hong Kong Med J  ⎥  Volume 24 Number 1  ⎥  February 2018  ⎥  www.hkmj.org
trials regarding thrombectomy for posterior 
circulation large-vessel occlusion or paediatric 
patients.
Contemporary thrombectomy devices
One major improvement of these five trials8-12 
compared with previous negative thrombectomy 
trials5-7 was the exclusive use of newer stent retriever 
devices and a consequent higher recanalisation rate. 
Near-complete/complete (TICI 2b/3) recanalisation 
was achieved in 59% to 88% of patients, compared 
with only 25% to 41% in early studies that used intra-
arterial tPA and first-generation devices.14
 Another contemporary thrombectomy 
device was the direct aspiration catheter (ADAPT 
technique),15 which applied suction to remove the 
clot via a large-bore endovascular catheter (Fig 1). 
This technique was supported by multiple single-
centre series that showed comparable and sometimes 
superior results over stent retrievers, although none 
of these were head-to-head comparative trials.16-18 
The 2016 THERAPY trial was the only randomised 
study to compare aspiration thrombectomy versus 
IV-tPA alone.19 It was terminated prematurely 
with a limited sample size after publication of the 
positive stent retriever trials, and as such failed 
to demonstrate a statistically significant benefit 
for aspiration thrombectomy over intravenous 
thrombolysis alone.
Cost-effectiveness of thrombectomy
Cost-utility analyses have been performed in several 
health care systems around the world and all have 
shown the cost-effectiveness of endovascular 
thrombectomy. The cost per quality-adjusted 
life year (QALY) gained for thrombectomy over 
standard thrombolysis treatment varies between 
US$7988 (Sweden), US$9386 (US), US$11 651 (UK), 
and US$11 990 (Canada).18,20-22 Using internationally 
accepted willingness-to-pay per QALY threshold 
of the gross domestic product per capita, all of 
the above health care systems found endovascular 
thrombectomy to be cost-effective.
International guidelines
The overwhelming clinical evidence to support 
application of thrombectomy in anterior circulation 
stroke prompted the European Stroke Organisation 
(ESO) and subsequently the American Heart 
Association/American Stroke Association (AHA/
ASA) to release a focused update of early stroke 
treatment guidelines in 2015, recommending 
endovascular thrombectomy with stent retriever 
device if onset of symptoms was within 6 hours and 
was due to a major vessel occlusion of the anterior 
circulation, and when suitable criteria were met 
(Class I, Level of Evidence A).23,24 The Box lists 
the latest AHA/ASA and ESO recommendations 
regarding endovascular thrombectomy.23,24 
Emergency thrombectomy in Hong 
Kong
Endovascular thrombectomy for ischaemic stroke 
is a relatively new procedure in Hong Kong and is 
not routinely available. Although it was practised in 
certain centres prior to 2015 for selected cases,25 there 
was no consensus on treatment indications, patient 
selection criteria, or operative techniques. With 
acute mechanical thrombectomy now becoming 
the international standard of care for acute anterior 
circulation ischaemic stroke, we undertook a survey 
to identify the availability, clinical practice, and 
potential obstacles of an acute stroke thrombectomy 
service in Hong Kong.
Design of the survey
We designed a survey which addressed the availability 
FIG 1.  (a) Angiogram showing acute occlusion of the right middle cerebral artery (arrow). (b) Post-thrombectomy angiogram 
showing revascularisation of the right middle cerebral artery territory. (c) Thrombus removed by endovascular thrombectomy
(a) (b) (c)
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of expertise, the indications, patient selection for 
stroke treatment, interventional techniques, and 
perceived obstacles to timely stroke treatment. This 
was a web-based survey consisting of 43 questions 
and was administered from May to August 2016. 
Respondents were drawn from the Hong Kong Stroke 
Society, Hong Kong Neurosurgical Society, and Hong 
Kong Society of Interventional and Therapeutic 
Neuroradiology. Invitations to participate were sent 
by email. Participants did not receive any incentive 
to complete this survey. We received 44 responses 
from the three societies. Background characteristics 
of the respondents are shown in Figure 2.
Service availability
Overall, 24 (54.5%) respondents from six public 
hospitals and five private practices were regularly 
involved in the decision and provision of mechanical 
thrombectomy for patients with acute ischaemic 
stroke. Most were neurosurgeons (75.0%), and the 
remainder were neurologists and interventional 
radiologists. In most centres, the interventionist 
capable of performing thrombectomy was a 
neurosurgeon or interventional radiologist, 
whereas in half of the responding centres there 
were also neurologists who were able to perform 
this procedure. For the majority of interventionists 
(62.5%), mechanical thrombectomy was offered only 
on an ‘ad hoc’ basis with no official service hours. The 
mean number of interventionists currently available 
was 4.3 per centre. The questions and responses of 
the survey are shown in Table 2. 
Clinical practice
Direct aspiration technique (ADAPT15) was the 
most popular first-line thrombectomy technique, 
American Heart Association/American Stroke Association 201524
Patients should receive endovascular therapy with a stent retriever when all of the following are met (Class I, Level of Evidence A):
•	 pre-stroke	modified	Rankin	score	0	to	1
•	 acute	ischaemic	stroke	receiving	IV-tPA	within	4.5	hours	according	to	guidelines
•	 causative	occlusion	of	the	internal	carotid	artery	or	proximal	middle	cerebral	artery	(M1)
•	 age	≥18 years
•	 NIHSS	score	≥6 
•	 ASPECTS	≥6 
•	 Treatment	can	be	initiated	within	6	hours	from	symptom	onset
European Stroke Organisation–KSU 201523
1.	 Mechanical	thrombectomy,	in	addition	to	intravenous	thrombolysis	within	4.5	hours	when	eligible,	is	recommended	to	treat	acute	stroke	
patients with large artery occlusions in the anterior circulation up to 6 hours after symptom onset (Grade A, Level 1a, KSU Grade A). 
2.	 Mechanical	thrombectomy	should	not	prevent	the	initiation	of	intravenous	thrombolysis	where	this	is	indicated,	and	intravenous	thrombolysis	
should	not	delay	mechanical	thrombectomy	(Grade	A,	Level	1a,	KSU	Grade	A).	
3.	 Mechanical	thrombectomy	should	be	performed	as	soon	as	possible	after	its	indication	(Grade	A,	Level	1a,	KSU	Grade	A).	
4.	 For	mechanical	thrombectomy,	stent	retrievers	approved	by	local	health	authorities	should	primarily	be	considered	(Grade	A,	Level	1a,	KSU	
Grade A).
5.	 If	intravenous	thrombolysis	is	contra-indicated	(eg	warfarin-treated	with	therapeutic	INR),	mechanical	thrombectomy	is	recommended	as	
first-line	treatment	in	large	vessel	occlusions	(Grade	A,	Level	1a,	KSU	Grade	A).
BOX.  New international guidelines for endovascular thrombectomy23,24
Abbreviations: ASPECTS = Alberta Stroke Program Early CT Score; INR = international normalised ratio; IV-tPA = intravenous thrombolysis with tissue 
plasminogen activator; KSU = Karolinska Stroke Update; NIHSS = National Institutes of Health Stroke Scale
FIG 2.  Background characteristics of respondents (n=44) 
Abbreviation: A&E = accident and emergency
Institution
Specialty
Experience
Public hospital (75.0%)
Neurosurgery (56.8%)
Specialist >5 years (68.2%)
Academic 
unit (13.6%)
Radiology 
(11.4%)
Specialist ≤5 years 
(18.2%)
Non-
specialist 
(13.6%)
A&E 
(6.8%)Neurology (25.0%)
Private 
practice 
(11.4%)
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TABLE 2.  Questions and responses on endovascular thrombectomy for acute ischaemic stroke (n=24)
Question Choices % Of respondents
1.	 What	is	the	availability	of	emergency	mechanical	
thrombectomy	service	for	acute	ischaemic	stroke	at	your	
centre?
-	 On	ad-hoc	basis,	no	official	available	time
-	 Available	during	specific	office	hours	(eg	9	am	to	5	pm)
-	 Always	available,	24	hours/7	days
- 62.5
- 33.3
- 4.2
2.	 If	acute	ischaemic	stroke	treatment	(IV-tPA	thrombolysis	
and/or	endovascular	treatment)	is	not	available	at	your	
centre,	or	when	it	is	outside	the	available	hours,	is	there	 
a	formal	acute	stroke	referral/diversion	pathway?
- Yes 
- No
- 10.0
- 90.0
3.	 In	your	centre,	who	is	capable	of	performing	mechanical	
thrombectomy?
- Neurosurgeon 
- Interventional radiologist 
- Neurologist 
- Other
- 100
- 100
- 50.0
- 4.2
4. In the past 12 months, how many patients were treated 
with	mechanical	thrombectomy	at	your	centre?
- ≤5
- 6-10
- 11-20
- 21-30
- >30
- 0
- 62.5
- 33.3
- 4.2
- 0
5.	 What	is	the	maximum	time	window	from	stroke	onset	for	
performing	mechanical	thrombectomy	in	patients	with	
anterior	circulation	stroke?
- ≤4.5 Hours
- ≤6 Hours
- ≤8 Hours
- ≤12 Hours
- Other
- 0
- 62.5
- 33.3
- 4.2
- 0
6.	 What	is	the	maximum	time	window	from	stroke	onset	for	
performing	mechanical	thrombectomy	in	patients	with	
posterior	circulation	stroke?
-	 No	specific	time	window
- ≤4.5 Hours
- ≤6 Hours
- ≤8 Hours
- ≤12 Hours
- ≤24 Hours
- Other
- 37.5
- 0
- 12.5
- 12.5
- 8.3
- 25.0
- 4.2
7. What is the imaging modality used to decide whether the 
patient	can	proceed	with	mechanical	thrombectomy?	(can	
choose more than 1 answer)
- CT angiogram
-	 Digital	subtraction	angiogram
- MR angiogram
- DWI MRI
-	 T1-/T2-weighted	MRI
-	 PWI/FLAIR	MRI
- CT perfusion scan
- Other
- 87.5
- 25.0
- 20.8
- 16.7
- 12.5
- 12.5
- 8.3
- 4.2
8. What are the patient selection criteria for mechanical 
thrombectomy	in	your	practice?	(can	choose	more	than	 
1 answer)
-	 M1/M2	occlusion
- Intracranial internal carotid artery occlusion
- Basilar artery occlusion
- NIHSS score >5
-	 Contra-indications	to	IV-tPA	thrombolysis
-	 Pre-stroke	mRS	score	≤2
-	 Failed	IV-tPA	thrombolysis
- NIHSS score <21
- Evidence of MRI diffusion-perfusion mismatch
- CT perfusion assessment
- PCA occlusion
- ACA occlusion
- Age <80 years
- Other
- 91.7
- 87.5
- 87.5
- 75.0
- 75.0
- 70.8
- 54.2
- 33.3
- 25.0
- 16.7
- 20.8
- 37.5
- 37.5
- 4.2
9. In your practice, what are the imaging parameters that 
contra-indicate	mechanical	thrombectomy?	(can	choose	
more than 1 answer)
-	 Evidence	of	midline	shift/mass	effect
- ASPECTS ≤6	on	non-contrast	CT/DWI	MRI
-	 Ischaemic	region	>1/2	MCA	territory
- M2 segment of MCA occlusion
- Tandem ICA+MCA occlusion
-	 Evidence	of	microbleeds	on	presentation
- Evidence of poor collateral circulation
-	 Ischaemic	regions	involving	both	anterior	and	posterior	
circulation territory
- Ischaemic core lesion volume >70 mL
- Other
- 79.2
- 58.3
- 45.8
- 12.5
- 0
- 29.2
- 20.8
- 25.0
- 25.0
- 0
10. What is the preferred mode of anaesthesia for 
endovascular	thrombectomy?
- Local anaesthesia
- Monitored anaesthetic care
- General anaesthesia
- 54.2
- 33.3
- 12.5
Abbreviations: ACA = anterior cerebral artery; ASPECTS = Alberta Stroke Program Early CT Score; CT = computed tomography; DWI = diffusion-
weighted imaging; FLAIR = fluid-attenuation inversion recovery; ICA = internal carotid artery; IV-tPA = intravenous thrombolysis with tissue plasminogen 
activator; MCA = middle cerebral artery; MR = magnetic resonance; MRI = magnetic resonance imaging; mRS = modified Rankin scale; NIHSS = National 
Institutes of Health Stroke Scale; PCA = posterior cerebral artery; PWI = perfusion-weighted imaging
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adopted by 83.3% of respondents. A stent retriever 
was chosen as a second-line thrombectomy device 
by 91.7% of interventionists. The majority of local 
practitioners used 6 hours as the time limit for 
anterior circulation thrombectomy in accordance 
with current guidelines, but a significant number of 
respondents (37.5%) adopted a more liberal limit of 8 
hours or beyond. Most practitioners would prescribe 
intravenous thrombolysis using the standard dosage 
in patients who fulfilled thrombolysis indications, 
regardless of thrombectomy decision, and in line 
with current guidelines.
 For patient selection, most local interventionists 
used CT angiography as the predominant imaging 
modality. This finding is unsurprising considering 
CT perfusion and MRI scanners were not routinely 
available in an emergency setting in many public 
hospitals where most acute stroke patients were 
treated. Apart from angiographic evidence of major 
vessel occlusion (intracranial internal carotid artery, 
M1/M2 segment of middle cerebral artery and basilar 
artery), stroke symptom severity of NIHSS score of 
>5 and pre-stroke functional status (mRS score ≤2) 
were regarded as important selection criteria by over 
70% of respondents. 
 Up to 87.5% of respondents performed 
thrombectomy without general anaesthesia. This 
practice has been recommended after a recent 
meta-analysis that confirmed better outcome in 
patients treated under conscious sedation than in 
those under general anaesthesia.26 A more recent 
randomised trial, however, showed no difference in 
outcome whether general anaesthesia or conscious 
sedation was used.27 
Incorporating emergency 
thrombectomy in acute stroke  
care in Hong Kong
Locally, an acute ischaemic stroke service is heavily 
dependent on a public health system that handles 
over 80% of emergency hospital admissions in Hong 
Question Choices % Of respondents
11. In your centre, what is the mean door-to-groin puncture 
time?
- ≤30 Mins
- 31-60 Mins
- 61-90 Mins
- 91-120 Mins
- 121-180 Mins
- >180 Mins
- 0
- 25.0
- 45.8
- 12.5
- 16.7
- 0
12.	Do	you	give	combined	IV-tPA	to	mechanical	
thrombectomy–indicated	patients?*
- No
- Yes, as standard treatment if within therapeutic window 
of	intravenous	thrombolysis
-	 Yes,	with	reduced	dose	before	endovascular	treatment	 
as	a	bridging	therapy	
- Yes, after endovascular treatment for incomplete 
recanalisation	or	distal	emboli
- 12.5
- 70.8
- 0
- 4.2
13. What is the dosage of tissue plasminogen activator if the 
patient	receives	both	treatments?
- Unchanged, as the standard dosage recommended 
IV-tPA dosage
- ¾ Dose of standard IV-tPA
- ½ Dose of standard IV-tPA
- ¼ Dose of standard IV-tPA
- I do not give concomitant IV-tPA
- 88.8
- 0
- 5.6
- 5.6
- 0
14.	What	do	you	use	as	the	first-line	device	for	mechanical	
thrombectomy?
-	 Penumbra	ACE64/Penumbra	System	MAX	(Penumbra,	
Inc, Alameda [CA], US)
- Solitaire FR (Medtronic, Minneapolis [MN], US)
-	 Trevo	(Stryker,	Fremont	[CA],	US)
-	 Merci	(Concentric	Medical;	Stryker,	Fremont,	[CA],	US)
- Other
- 83.3
- 8.3
- 4.2
- 0
- 4.2
15. What do you use as a second-line device for mechanical 
thrombectomy	if	the	first-line	failed?
- Solitaire FR (Medtronic, Minneapolis [MN], US)
-	 Trevo	(Stryker,	Fremont	[CA],US)
-	 Merci	(Concentric	Medical;	Stryker,	Fremont	[CA],US)
-	 Penumbra	ACE64/Penumbra	System	MAX	(Penumbra,	
Inc, Alameda [CA], US)
- Other
- 45.8
- 41.7
- 0
- 8.3
- 4.2
16. Do you use systemic heparin or other anticoagulants during 
the endovascular procedure?
- Yes 
- No
- 29.2
- 70.8
17. Do you give any antiplatelets or anticoagulants to patients 
soon	after	the	thrombectomy?
- Yes 
- No
- Other
- 29.2
- 58.3
- 12.5
TABLE 2.  (cont'd)
* The percentages do not total 100 because of missing data
#  Emergency thrombectomy for acute ischaemic stroke  # 
79Hong Kong Med J  ⎥  Volume 24 Number 1  ⎥  February 2018  ⎥  www.hkmj.org
FIG 3.  Treatment algorithm for patients with acute ischaemic stroke
Abbreviations: CT = computed tomography; IV-tPA = intravenous thrombolysis with 
tissue plasminogen activator
Acute stroke symptoms
Ambulance diversion to primary stroke 
centre (with 24/7 IV-tPA)
IV-tPA after CT brain confirming diagnosis 
(<4.5 hours)
Suspicious of major vessel 
occlusion
Urgent CT angiogram 
confirming major vessel 
occlusion
Emergency endovascular 
thrombectomy (<6 hours)
Yes
No
Not suspicious of major vessel 
occlusion
Stroke unit care
Kong.28 Our neurologists and stroke physicians in 
public hospitals have made major contributions over 
the past two decades in implementing intravenous 
thrombolysis and spearheading 24-hour acute stroke 
care. As a result of much effort, currently seven of 
17 emergency hospitals in the public hospital system 
provide 24-hour IV-tPA thrombolysis service.29 
Future enhancement of an acute stroke service 
should aim to provide timely and universal access 
for patients with acute ischaemic stroke, and divert 
potentially eligible thrombectomy patients to centres 
that can provide such service (Fig 3).
 Our survey identified the most common 
reported obstacles in implementing prompt stroke 
interventions as poor inter- and in-hospital logistics 
of patient transfer and triage, delayed presentation, 
and insufficient interventionists, as well as difficulty 
in obtaining emergency CT angiogram in an urgent 
setting.
 The two-tier primary and comprehensive 
stroke centre model that aims to give priority access 
to patients with suspected acute stroke may be seen 
as a framework for acute stroke service.30-32 The first-
tier stroke centre should be capable of providing 
24-hour urgent CT and CT angiogram with round-
the-clock IV-tPA service. All patients with suspicious 
stroke symptoms, such as acute hemiplegia or 
dysphasia, should be directly transferred to one 
of these first-tier stroke centres, bypassing other 
non-stroke centres in emergency hospitals to avoid 
unnecessary delay in diagnosis. When major vessel 
occlusion is suspected, immediate CT angiography 
should be performed in the same setting to 
determine thrombectomy eligibility. Second-
tier stroke centres should additionally be capable 
of 24-hour endovascular thrombectomy, and be 
equipped with full-time neurosurgery, neurocritical 
care, and advanced radiological imaging support.31 
Among the local stroke specialists, a median 
number of four second-tier comprehensive stroke 
centres is believed to be appropriate in Hong Kong. 
Support from the health administration, structured 
training for endovascular techniques, and efficient 
use of existing resources are required to effectively 
incorporate emergency thrombectomy into routine 
clinical service locally.
Conclusion
There is a strong body of clinical evidence and 
international guidelines to support emergency 
endovascular thrombectomy for acute ischaemic 
stroke due to anterior circulation major vessel 
occlusion. As the local stroke community embraces 
this new treatment modality, efforts should be 
directed towards providing universal and timely 
access to emergency ischaemic stroke therapy for 
the Hong Kong population. 
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